SCHEMBL6703523

SCHEMBL6703523

CCOC(=O)c1cn2c(n1)sc1ccc(OC)cc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP15 Q460N3 1/20 0.49
PARP10 Q53GL7 1/20 0.49
TNKS2 Q9H2K2 1/20 0.49
PARP2 Q9UGN5 1/20 0.49
MAPT P10636 5/20 0.48
TP53 P04637 2/20 0.48
GABRA2 P47869 2/20 0.47
GABRB2 P47870 2/20 0.47
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 2/20 0.46
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
GAA P10253 2/20 0.45
LMNA P02545 2/20 0.44
HSP90AA1 P07900 1/20 0.44
TSHR P16473 1/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HPGD P15428 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2921213 0.91 MAPT (0.56) PARP15PARP10TNKS2PARP2MAPT
SCHEMBL6702652 0.85 GABRA2 (0.49) GABRA2GABRB2GAA
SCHEMBL20518828 0.82 PARP15 (0.47) PARP15PARP10TNKS2PARP2MAPT
SCHEMBL20518797 0.82 MAPT (0.47) MAPTTP53GABRA2GABRB2KDM4E
SCHEMBL2922603 0.82 GAA (0.53) MAPTTP53GABRA2GABRB2KDM4E
SCHEMBL17620797 0.80 TP53 (0.46) MAPTTP53GABRA2GABRB2KDM4E
SCHEMBL2922938 0.80 MAPT (0.53) PARP15PARP10TNKS2PARP2MAPT
SCHEMBL10427455 0.79 PARP15 (0.49) PARP15PARP10TNKS2PARP2MAPT
SCHEMBL17620680 0.79 MAPT (0.53) MAPTTP53KDM4EALDH1A1RAB9A
SCHEMBL17621033 0.79 MAPT (0.53) PARP15PARP10TNKS2PARP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040053913-A1 Process for preparing 6-alkylidene penem derivatives WYETH 2004-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053913-A1 Process for preparing 6-alkylidene penem derivatives PGM2, BPGM, MRPL21 PARP15 427/4885PARP10 232/4885TNKS2 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.